deltatrials
Completed NCT00002695

Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck

CLINICAL EFFICACY OF MOLECULAR ANALYSIS OF SURGICAL MARGINS AND REGIONAL LYMPH NODES IN MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA

Sponsor: ECOG-ACRIN Cancer Research Group

Conditions Head and Neck Cancer
Interventions DNA stability analysis laboratory biomarker analysis microsatellite instability analysis mutation analysis
Updated 8 times since 2017 Last updated: Jun 20, 2023 Started: Apr 30, 1996 Primary completion: Oct 18, 2002 Completion: May 27, 2011

A observational or N/A phase clinical study on Head and Neck Cancer, this trial is completed. The trial is conducted by ECOG-ACRIN Cancer Research Group and has accumulated 8 data snapshots since 1996. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jul 2023 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2023 [monthly]

    Completed

  5. Jun 2018 — Jan 2021 [monthly]

    Completed

▶ Show 3 earlier versions

  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  2. Jun 2017 — Apr 2018 [monthly]

    Completed NA

    Status: Unknown Status → Completed

  3. Jan 2017 — Jun 2017 [monthly]

    Unknown Status NA

    First recorded

Apr 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ECOG-ACRIN Cancer Research Group
  • National Cancer Institute (NCI)
Data source: Eastern Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Baltimore, United States
  • • Cleveland, United States
  • • Green Bay, United States
  • • Philadelphia, United States